<DOC>
	<DOC>NCT01151540</DOC>
	<brief_summary>To investigate the safety of long term administration of E2080 in the patients with Lennox-Gastaut syndrome who completed the E2080-J081-304 Study.</brief_summary>
	<brief_title>A Long Term Extension Study of E2080 in Lennox-Gastaut Patients</brief_title>
	<detailed_description />
	<mesh_term>Lennox Gastaut Syndrome</mesh_term>
	<criteria>Inclusion criteria; 1. Patients who have completed the evaluation of week 12 of the E2080J081304 Study 2. Patients who have provided a written informed consent to participate in this clinical trial until the evaluation of week 12 of the E2080J081304 Study Exclusion criteria; 1. Patients who were judged by the investigator that they are unfit to participate in this clinical study for safety reasons based on the information up to the evaluation of week 12 of the E2080J081304 Study. 2. Patients who were judged by the investigator that they are likely to become noncompliant with administration during the clinical trial period. 3. Patients who were judged by the investigator that they were unfit to participate in this clinical trial.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Epilepsy</keyword>
	<keyword>Seizures</keyword>
</DOC>